Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-400 vs Systane for Quality of Vision after LASIK
NCT00627302Phase 4Completed
- Sponsor
- BP Consulting
- Start
- Feb 2008
- Primary completion
- Nov 2008
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in dry eye syndrome (DED) comparing PEG-400 with Systane (2 arms). Primary endpoint: Quality of vision at 5 months. Started Feb 2008; status: completed.
02
Drugs
polyethylene glycol 400lanolin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00627302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627302.